The hypoxic tumor microenvironment induces hypoxia-inducible factor 1α (HIF-1 α), leading to the upregulation of adenosinergic molecules, including CD39, CD73, and the adenosine receptor A2BR [34,116]. Here, ENTPD1 is linked to neoplasm.